Steven Cohen Sangamo Therapeutics, Inc Transaction History

Point72 Asset Management, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$1.11 - $1.74 $30,551 - $47,891	-27,524 Reduced 72.86%	10,252 $13,000
Q1 2023 May 15, 2023	BUY	$1.66 - $3.67 $62,708 - $138,637	37,776 New	37,776 $66,000
Q2 2021 Aug 16, 2021	SELL	$10.17 - $12.64 $6.92 Million - $8.6 Million	-680,200 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$10.88 - $17.05 $7.4 Million - $11.6 Million	680,200 New	680,200 $8.52 Million
Q4 2017 Feb 14, 2018	SELL	$11.6 - $17.35 $8.04 Million - $12 Million	-693,300 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$8.4 - $15.0 $5.82 Million - $10.4 Million	693,300	693,300 $10.4 Million

133

86.3M

35.9K

156K

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $136M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.